选择语言

Recombinant Monoclonal Anti-PD-1 Antibody, Mouse (2F3)

用户评价
货号-规格
价格
Qty.
HGS-S238-20ul
¥1280.00
HGS-S238-100ul
¥4450.00
合计0件 产品金额¥ 0

产品详情

  • 描述/背景(Background)

    Programmed cell death protein 1 (PDCD1) is an immune-inhibitory receptor expressed in activated T cells; it is involved in the regulation of T-cell functions, including those of effector CD8+ T cells. In addition, this protein can also promote the differentiation of CD4+ T cells into T regulatory cells. PDCD1 is expressed in many types of tumors including melanomas, and has demonstrated to play a role in anti-tumor immunity. Moreover, this protein has been shown to be involved in safeguarding against autoimmunity, however, it can also contribute to the inhibition of effective anti-tumor and anti-microbial immunity.

  • 种属(Host Species)

    Mouse

  • 克隆号(Clone)

    2F3

  • 适用方法(Application)

    IHC

  • 效价(Property)

    1:500

  • 状态(State)

    Liquid

  • 阳性对照(Positive Control)

    Human Tonsil Tissues

  • 克隆类型(Clonality)

    Monoclonal

  • 分子别名(Synonym)

    PD1, CD279, PD-1, PDCD1

  • 研究领域(Research Field)

    Cancer Drug Targets

  • 抗体来源(Source)

    Mouse

  • 同种型(Isotype)

    IgG

  • 储存(Storage)

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

典型数据(Typical Data)
  • 质控样本(Control Sample)

     PD-1 CONTROL SAMPLE

    Immunohistochemical analysis of paraffin embedded Human tonsil tissue labelled with HGS-S238 at 1/500 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

  • 肿瘤样本(Cancer Sample)

     PD-1 CANCER SAMPLE
     PD-1 CANCER SAMPLE

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S238 at 1/500 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Programmed cell death protein 1

  • 中文全称:

    细胞程序性死亡-1

  • 种类:

  • 上市药物数量:

    20 详情

  • 临床药物数量:

    167 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价